Evidence map›Paper›PMID 34452065›Full record

ArticlePharmaceutics2021

Interaction of a Short Peptide with G-Quadruplex-Forming Sequences: An SRCD and CD Study.

Claudia Honisch, Eugenio Ragazzi, Rohanah Hussain, John Brazier, Giuliano Siligardi, Paolo Ruzza

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. A Novel Cell-Penetrating Lipopeptide for DNA Binding, Self-Assembly, and Delivery Into HeLa and Pluripotent Stem Cells.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. A CD Study of a Structure-Based Selection ofMolecules (Basel, Switzerland) · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Claudia HonischInstitute of Biomolecular Chemistry of CNR, Via F. Marzolo, 1, 35131 Padova, Italy.ORCID 0000-0001-9720-6176
Eugenio RagazziDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Largo Meneghetti, 2, 35131 Padova, Italy.ORCID 0000-0002-0390-6823
Rohanah HussainDiamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.
John BrazierSchool of Pharmacy, University of Reading, Reading RG6 6DX, UK.
Giuliano SiligardiDiamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.ORCID 0000-0002-4667-6423
Paolo RuzzaInstitute of Biomolecular Chemistry of CNR, Via F. Marzolo, 1, 35131 Padova, Italy.ORCID 0000-0002-5596-9295
Diamond Light Source · GBUniversity of Padua · ITInstitute of Protein Biochemistry · ITUniversity of Reading · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G-quadruplex (G4) forming DNA sequences were recently found to play a crucial role in the regulation of genomic processes such as replication, transcription and translation, also related to serious diseases. Therefore, systems capable of controlling DNA and RNA G-quadruplex structures would be useful for the modulation of various cellular events. In particular, peptides represent good candidates for targeting G-quadruplex structures, since they are easily tailored to enhance their functionality. In this work, we analyzed, by circular dichroism and synchrotron radiation circular dichroism spectroscopies, the interaction of a 25-residue peptide deriving from RHAU helicases (

Indexed as

G-quadruplex DNApeptidephoto-stability

Identifiers

PMID34452065
PMCPMC8401852
OpenAlexW3184503255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.